OncoSec Enters into a Collaboration Agreement with Merck for a Pivotal Global Phase 3 Study …,

The planned clinical trial will evaluate the overall survival of patients treated with the TAVO™ in combination with KEYTRUDA® versus standard of …, The planned clinical trial will evaluate the overall survival of patients treated with the TAVO™ in combination with KEYTRUDA® versus standard of …, Read More

Scroll to Top